Fine-actingYep,
There must be something behind that.....
Lets say, that volume is getting higher, attention on the stock also,
More visibility about oncology,
Fast track,
Year to date, the stock is not doing bad,
Even here on the stockhouse, lots of good discussions,
Maybe the management will be proven right,
They did a good Fine-acting, and doing and good job putting THERA back on the map for the good reason (pipeline, sales, ...)
FTV.